Jubilant Pharmova Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 16,336.8 million compared to INR 15,497.9 million a year ago. Revenue was INR 16,619 million compared to INR 15,948 million a year ago. Net income was INR 1,428.4 million compared to INR 2,240.3 million a year ago. Basic earnings per share from continuing operations was INR 8.97 compared to INR 9.21 a year ago. Diluted earnings per share from continuing operations was INR 8.97 compared to INR 9.21 a year ago. Basic earnings per share was INR 8.97 compared to INR 14.06 a year ago. Diluted earnings per share was INR 8.97 compared to INR 14.06 a year ago. For the six months, sales was INR 32,471.3 million compared to INR 26,685.6 million a year ago. Revenue was INR 33,004.4 million compared to INR 27,547.8 million a year ago. Net income was INR 3,034 million compared to INR 3,120.4 million a year ago. Basic earnings per share from continuing operations was INR 19.06 compared to INR 11.44 a year ago. Diluted earnings per share from continuing operations was INR 19.06 compared to INR 11.44 a year ago. Basic earnings per share was INR 19.06 compared to INR 19.59 a year ago. Diluted earnings per share was INR 19.06 compared to INR 19.59 a year ago.